Cours Satsuma Pharmaceuticals, Inc.
Actions
STSA
US80405P1075
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 63 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Director/Board Member | 64 | 08/06/23 | |
Ken Takanashi
BRD | Director/Board Member | 60 | 01/06/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,60 % | 106 Md | |
-4,68 % | 24,28 Md | |
-0,67 % | 21,96 Md | |
-8,82 % | 18,16 Md | |
-42,12 % | 16,37 Md | |
-17,47 % | 15,56 Md | |
+2,77 % | 13,63 Md | |
+34,58 % | 12,27 Md | |
+77,64 % | 8,87 Md |